Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122530) titled 'Comparison of the Efficacy and Safety of Vonoprazan Combined with Tetracycline versus Vonoprazan Combined with Amoxicillin Dual Regimens for Helicobacter pylori Eradication: A Prospective, Multicenter, Randomized Controlled Study' on April 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The first affiliated hostipal of nanchang university
Condition:
helicobacter pylori infection
Intervention:
vonoprazan combined with amoxicillin dual therapy:vonoprazan 20mg twice daily, Amoxicillin 1000mg three times daily, for a 14-day duration.
Recruitment Status: Recruiting
Phase: 4
Da...